Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells.
about
Prodrug Strategies for PaclitaxelAn ambiguity principle for assigning protein structural domainsNek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer.Site specific replacements of a single loop nucleoside with a dibenzyl linker may switch the activity of TBA from anticoagulant to antiproliferative.hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance.Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament.Advancements in tetronic acid chemistry. Part 2: Use as a simple precursor to privileged heterocyclic motifs.Use of Integrated Computational Approaches in the Search for New Therapeutic Agents.Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.Simulation Study of cDNA Dataset to Investigate Possible Association of Differentially Expressed Genes of Human THP1-Monocytic Cells in Cancer Progression Affected by Bacterial Shiga Toxins.Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer
P2860
Q26745997-D7B85CB5-AF3F-4DE6-9957-783D4DA3B8A7Q30397624-0B9261A2-9C23-4014-904F-90AB52764C6FQ35929796-4474AAE9-12ED-42EE-A339-9689DBC9C813Q36299184-AA8BFF3A-439B-4336-A58F-3DA188FA99EAQ37580494-38153C89-4A42-42FF-A12F-A29D98678F4EQ38700921-A1A0D43E-2065-4DB0-A6EA-FE5F2201D58FQ38878965-9493B07C-35C3-43C6-AB6B-DDB7DBA61630Q38933291-71AB9A70-717A-42C4-B706-0182C90F7BEAQ47121717-35ED7194-7C2B-4003-8509-351677C67465Q52338743-9FD2C2AA-AEBA-4886-A98C-B8579EC14459Q57817294-8CEF34FA-EBBE-4185-B468-0FDF2AF7A105
P2860
Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification of the first in ...... itaxel resistant cancer cells.
@ast
Identification of the first in ...... itaxel resistant cancer cells.
@en
Identification of the first in ...... itaxel resistant cancer cells.
@nl
type
label
Identification of the first in ...... itaxel resistant cancer cells.
@ast
Identification of the first in ...... itaxel resistant cancer cells.
@en
Identification of the first in ...... itaxel resistant cancer cells.
@nl
prefLabel
Identification of the first in ...... itaxel resistant cancer cells.
@ast
Identification of the first in ...... itaxel resistant cancer cells.
@en
Identification of the first in ...... itaxel resistant cancer cells.
@nl
P2093
P2860
P50
P356
P1476
Identification of the first in ...... litaxel resistant cancer cells
@en
P2093
Ajay Kumar
Antonella Pepe
Antonio E Alegria
Cristiano Ferlini
Giovanni Scambia
Laima Sevciunaite
Marisa Mariani
Mirko Andreoli
Nausicaa Orteca
Sakkarapalayam Mahalingam
P2860
P304
P356
10.1021/JM5009902
P407
P50
P577
2014-09-26T00:00:00Z